Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael S. Aberman currently holds 4,693 shares of REGENERON PHARMACEUTICALS INC (REGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael S. Aberman has been a net seller of REGN stock. They have purchased $0 and sold $16.9M worth of shares.
Michael S. Aberman's most recent insider trade was on Jun 22, 2017, when they sold 100 shares at $541.00 per share.
Michael S. Aberman serves as Executive at REGENERON PHARMACEUTICALS INC (REGN). They have executed 116 insider transactions totaling $16.9M over their tenure at the company.
Michael S. Aberman holds the position of Executive at REGENERON PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 16 years and currently hold a stake valued at $0.
Michael S. Aberman has shown a selling trading pattern, with $0 in total purchases and $16.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Michael S. Aberman was on Mar 23, 2015, when they sold $2.5M worth of REGN shares. This transaction involved 5,157 shares at $476.50 per share.
Michael S. Aberman currently owns 4,693 shares of REGENERON PHARMACEUTICALS INC (REGN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael S. Aberman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael S. Aberman has 116 Form 4 filings on record as an insider at REGENERON PHARMACEUTICALS INC.
Set alerts for Michael S. Aberman and 40,000+ other insiders.